Adaptive Biotechnologies (ADPT) EBITDA Margin (2018 - 2026)
Adaptive Biotechnologies' (ADPT) quarterly EBITDA Margin came in at 22.04% in Q2 2026, down 1173.0% year-over-year from 2.05% in Q2 2025, and down 228.69% quarter-over-quarter from 17.13% in Q1 2026.
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) EBITDA Margin (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has disclosed EBITDA Margin across 9 years of filings, most recently posting 22.04% for Q2 2026.
- In Q2 2026, EBITDA Margin fell 1173.0% year-over-year to 22.04%; the TTM figure through Jun 2026 stood at 11.53% (up 2678.0% YoY), while the FY2025 annual figure was 9.19%, up 4586.0% from the prior year.
- EBITDA Margin came in at 22.04% for Q2 2026 at Adaptive Biotechnologies, down from 17.13% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 32.64% in Q3 2025 to a low of 163.3% in Q1 2022.
- Average EBITDA Margin over 5 years is 46.61%, with a median of 40.23% recorded in 2024.
- The largest YoY upside for EBITDA Margin was 9140 bps in 2022 against a maximum downside of 5592 bps in 2022.
- Over 5 years, EBITDA Margin stood at 70.99% in 2022, then soared by 69 bps to 21.75% in 2023, then surged by 83 bps to 3.61% in 2024, then soared by 428 bps to 11.84% in 2025, then tumbled by 286 bps to 22.04% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 22.04% in Q2 2026, 17.13% in Q1 2026, and 11.84% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -10.07% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 15.08% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 12.10% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -38.55% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | -19.85% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 10.21% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 34.17% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 5.03% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -22.04% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -1.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.04% |
| Mar 31, 2026 | 17.13% |
| Dec 31, 2025 | 11.84% |
| Sep 30, 2025 | 32.64% |
| Jun 30, 2025 | -10.31% |
| Mar 31, 2025 | -17.58% |
| Dec 31, 2024 | -3.61% |
| Sep 30, 2024 | -30.80% |
| Jun 30, 2024 | -49.66% |
| Mar 31, 2024 | -67.30% |
| Dec 31, 2023 | -21.75% |
| Sep 30, 2023 | -78.67% |
| Jun 30, 2023 | -50.73% |
| Mar 31, 2023 | -98.54% |
| Dec 31, 2022 | -70.99% |
| Sep 30, 2022 | -94.98% |
| Jun 30, 2022 | -120.25% |
| Mar 31, 2022 | -163.30% |
| Dec 31, 2021 | -162.39% |
| Sep 30, 2021 | -142.71% |